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The delegates of the 1st All Africa Workshop on Rheumatic 
Fever (RF) and Rheumatic Heart Disease (RHD) gathered at 
the Champagne Sports Resort in the Drakensberg, South Africa 
on 15 - 16 October 2005 are acutely aware of the fact that RF 
and RHD remain a major public health problem in Africa. 
Whereas Africa has 10% of the world population, as many as 
half of the 2.4 million children affected by RHD globally live 
on the continent. RHD accounts for a major proportion of all 
cardiovascular disease in children and young adults in African 
countries, and the disease has the potential to undermine 
national productivity, since young adults are the most 
productive segment of the population.
   We are mindful of the fact that the major determinants 
of RF and RHD are poverty, overcrowding, poor housing 
and shortage of health care resources. We call on African 
governments and the world community to accelerate 
investment the initiatives designed to improve the living 
conditions of the world’s poor, which will lead to the permanent 
eradication of RF/RHD in the long term. 
   In the short to medium term, we recognise that cost-effective 
strategies for the prevention (primary and secondary) and 
treatment (or tertiary prevention) of RF/RHD are available. We 
are aware that the primary, secondary and tertiary prevention 
of RF and RHD are woefully inadequate in almost all African 
countries. We note that the World Health Organization regards 
the establishment of national prevention programmes as 
an essential step in countries where RF and RHD remain 
significant health problems.1 We undertake to develop pilot 
programmes at selected sentinel sites that will ultimately serve 
as the basis for the establishment of national programmes for 
the control of RF/RHD in our individual countries.
   We furthermore support the development of a common 
programme that concentrates on four areas of activity: (i) 
raising the awareness of the public and health care workers 
with regard to RF and RHD; (ii) improving the quality of 
information available on the incidence, prevalence and 
burden of RF/RHD through epidemiological surveillance; 
(iii) working together as advocates to change public policy for 
the improvement of health care facilities needed to treat and 
prevent the disease; and (iv) working towards the establishment 
of national primary and secondary prevention programmes for 
RF and RHD. This programme, which is the called the A.S.A.P. 
programme, will be co-ordinated throughout Africa by the Pan 
African Society of Cardiology in collaboration with the World 
Heart Federation and the World Health Organization.
   We commit ourselves to meet on a regular basis to evaluate 
progress made in our efforts to control RF and RHD in Africa 
until the objectives of this action plan are achieved.
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